At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Q4 SPAN Meeting to Focus on the ASLP-IC Compact
The American Academy of Audiology’s State Policy Advocate Network (SPAN) will hold its fourth-quarter meeting on October 28, 2026, from 8:00–9:00 pm ET. The meeting…
Tympanostomy Tubes Found in the Middle Ear Space: A Case Report
The placement of pressure equalization (PE) tubes is common procedure and often used for management of otitis media with effusion (OME), recurrent acute otitis media…
Cochlear Implant SatisfactionÂ
Approximately 118,000 adults and 65,000 children in the United States have cochlear implants (CI) (National Institutes of Health, 2021). Most CIs require an external processor,…



